A phase Ib, proof-of-concept trial of anatabine in patients with mild to moderate psoriasis
Phase of Trial: Phase I
Latest Information Update: 11 Aug 2016
At a glance
- Drugs Anatabine (Primary)
- Indications Psoriasis
- Focus Adverse reactions; Proof of concept
- 11 Aug 2016 According to a Rock Creek Pharmaceuticals media release, initiation of this study is likely to be postponed from fourth quarter of 2016 to early first half of 2017.
- 16 May 2016 According to a Rock Creek Pharmaceuticals media release, the company expects to test therapeutic potential of anatabine in this study in Q4 of 2016.
- 15 Oct 2015 According to a Rock Creek Pharmaceuticals, Inc. media release, this trial is expected to commence in the first half of 2016.